Biomaterial-dependent blood activation during simulated extracorporeal circulation: a study of heparin-coated and uncoated circuits

被引:7
作者
Borowiec, JW [1 ]
Venge, P
Henze, A
Nilsson, B
Stiernstrom, H
机构
[1] Univ Uppsala Hosp, Dept Cardiothorac Surg, S-75185 Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Clin Chem, S-75185 Uppsala, Sweden
[3] Univ Uppsala Hosp, Dept Clin Immunol, S-75185 Uppsala, Sweden
[4] Univ Uppsala Hosp, Dept Anesthesiol, S-75185 Uppsala, Sweden
关键词
simulated extracorporeal circulation; blood activation; heparin coating; nitric oxide;
D O I
10.1055/s-2007-1013752
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Blood activation during extracorporeal circulation is associated with morbidity and mortality in cardiac surgery. This activation can be diminished by usage of heparin-coated circuits. Nitric oxide has also been reported to influence humoral and cellular components of blood. This study was performed to determine biomaterial-dependent part of blood activation. Design: Fresh, whole human blood mixed with Ringer's solution was circulated through a heart-lung machine for two and half hours. Five circuits were heparin-coated (group HC), whilst five other circuits were uncoated (group NC). During the last half hour NO was added to the oxygen/air mixture. Methods: Blood activation was estimated by measuring following parameters: interluekin 6, complement activation products C3a and terminal complement complex, and oxygen free radicals (OFR) production capacity, which was determined using chemiluminescence enhanced by serum opsonized zymosan (SOZ) and phorbol myristate acetate (PMA). Granulocyte activation was measured as release of myeloperoxidase (MPG) and human neutrophil lipocalin (HNL). Results: OFR in granulocyte suspension stimulated by SOZ and PMA were significantly lower in the NC group, mostly later during ECC. Similarly, lower neutrophil and monocyte counts were observed in this group. NO increased superoxide production in the whole blood in heparin-coated circuits, but did not change OFR in isolated granulocytes. MPO was also affected by heparin-coating. NO supply seemed to increase release of MPO and HNL. It is concluded that heparin-coating contributed to reduction of biomaterial-dependent blood activation. An addition of NO at late stage of ECC tended to influence this activation.
引用
收藏
页码:295 / 301
页数:7
相关论文
共 26 条
[1]  
BOROWIEC J, 1992, J THORAC CARDIOV SUR, V104, P642
[2]   Circulating cytokines and granulocyte-derived enzymes during complex heart surgery - A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits [J].
Borowiec, JW ;
Hagman, L ;
Totterman, TH ;
Pekna, M ;
Venge, P ;
Thelin, S .
SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 29 (04) :167-174
[3]   Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery [J].
Bozdayi, M ;
Borowiec, J ;
Nilsson, L ;
Venge, P ;
Thelin, S ;
Hansson, HE .
ARTIFICIAL ORGANS, 1996, 20 (09) :1008-1016
[4]   TIME-COURSE OF FREE-RADICAL ACTIVITY DURING CORONARY-ARTERY OPERATIONS WITH CARDIOPULMONARY BYPASS [J].
DAVIES, SW ;
DUFFY, JP ;
WICKENS, DG ;
UNDERWOOD, SM ;
HILL, A ;
ALLADINE, MF ;
FENECK, RO ;
DORMANDY, TL ;
WALESBY, RK .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 105 (06) :979-987
[5]  
ElHabbal MH, 1995, CARDIOVASC RES, V30, P676, DOI 10.1016/0008-6363(95)00069-0
[6]   DISPARATE EFFECTS OF NITRIC-OXIDE ON LUNG ISCHEMIA-REPERFUSION INJURY [J].
EPPINGER, MJ ;
WARD, PA ;
JONES, ML ;
BOLLING, SF ;
DEEB, GM .
ANNALS OF THORACIC SURGERY, 1995, 60 (05) :1169-1176
[7]  
FAYMONVILLE ME, 1991, J THORAC CARDIOV SUR, V102, P309
[8]   Effects of inhibition of complement activation using recombinant soluble complement receptor 1 on neutrophil CD11B/CD18 and L-selectin expression and release of interleukin-8 and elastase in simulated cardiopulmonary bypass [J].
Finn, A ;
Morgan, BP ;
Rebuck, N ;
Klein, N ;
Rogers, CA ;
Hibbs, M ;
Elliott, M ;
Shore, DF ;
Evans, TW ;
Strobel, S ;
Moat, N .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 111 (02) :451-459
[9]  
FUKUHARA K, 1997, EUR J CARDIO-THORAC, V11, P343
[10]   Inhaled nitric oxide: Therapeutic applications in cardiothoracic surgery [J].
Fullerton, DA ;
McIntyre, RC .
ANNALS OF THORACIC SURGERY, 1996, 61 (06) :1856-1864